Equities

Episurf Medical AB

Episurf Medical AB

Actions
  • Price (EUR)0.0001
  • Today's Change-0.004 / -97.62%
  • Shares traded500.00
  • 1 Year change-99.81%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments58155238
Total Receivables, Net1.902.803.20
Total Inventory3.701.901.90
Prepaid expenses1.501.101.30
Other current assets, total--(0.1)0.10
Total current assets65161244
Property, plant & equipment, net5.606.703.20
Goodwill, net------
Intangibles, net343023
Long term investments----0
Note receivable - long term------
Other long term assets----0
Total assets104197271
LIABILITIES
Accounts payable6.104.405.90
Accrued expenses6.406.004.90
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.902.502.10
Other current liabilities, total2.001.801.30
Total current liabilities171514
Total long term debt2.303.800.80
Total debt5.206.302.90
Deferred income tax------
Minority interest------
Other liabilities, total0.101.002.80
Total liabilities202018
SHAREHOLDERS EQUITY
Common stock808080
Additional paid-in capital685685684
Retained earnings (accumulated deficit)(681)(587)(512)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity85178253
Total liabilities & shareholders' equity104197271
Total common shares outstanding346346345
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.